Adjunctive Framework: Core & Supportive Modalities
Functional medicine approach integrated with ongoing neurological care.
Umbilical Cord Mesenchymal Stem Cells
Core adjunctive component. Umbilical cord MSCs are used for their immunomodulatory and anti‑inflammatory properties. Objective: support neural tissue homeostasis and regulate neuroinflammation. Minimally invasive administration. Performed under physician supervision.
Learn MorePhysical Therapy Protocol
Individualized physical rehabilitation protocol to maintain functional capacity, reduce spasticity, and support mobility. Integrated with regenerative therapy to improve quality of life. Evidence‑based, delivered by licensed therapists.
Explore ProtocolsNutritional Medicine Protocol
Assessment of metabolic and nutritional status, targeted nutrition protocol to provide essential substrates. Focus on anti‑inflammatory nutrition and mitochondrial support. Concurrent with conventional dietary management.
Get Personalized PlanTherapeutic Rationale: MSC Working Dynamics
The selection of umbilical cord‑derived mesenchymal stem cells is based on documented immunomodulatory and paracrine capabilities. These cells secrete bioactive molecules (cytokines, growth factors, exosomes) that influence the local neuroinflammatory environment.
When integrated with a structured physical therapy protocol (aimed at preserving function and reducing secondary complications) and a nutritional medicine protocol (targeting metabolic optimization), this approach represents a coordinated adjunctive strategy rather than a stand‑alone intervention.
Minimally invasive administration techniques are chosen to maximize cellular delivery while minimizing discomfort and procedural risk, consistent with contemporary medical practice for cellular therapies.
Medical Director, Nexus Stem Cells
Meet Our ProvidersScientific illustration
of paracrine signaling
Clinical Eligibility Considerations
Our clinical team evaluates several factors when assessing patients for this adjunctive approach. The following represent general considerations that guide patient evaluation:
- Documented diagnosis of ALS by a neurologist
- Comprehensive medical evaluation to assess overall health status
- Absence of contraindications to cellular therapy procedures
- Commitment to participate in all three components (MSC, physical therapy, nutrition)
- Realistic understanding of supportive goals and expected timeframe
- Willingness to undergo pre‑therapy assessments
- Continuation of conventional ALS treatments under neurologist guidance
Patients considering this adjunctive framework should maintain their current ALS management regimen (riluzole, edaravone, respiratory support, etc.) until a complete evaluation and coordinated plan has been established with our medical team and their primary neurologist.
ALS Mechanisms Reference Guide
Download our free reference summary on mesenchymal stem cell working dynamics for ALS — no sign‑up required.
Download PDF (from /resources)File available at /resources/als-msc-mechanisms-reference.pdf
Clinical Evaluation Pathway · ALS Support Framework
Comprehensive medical assessment prior to adjunctive framework consideration
Primary Neurological Consultation
Medical evaluation with our regenerative medicine specialist, review of current ALS treatments, determination of eligibility within the adjunctive framework.
Clinical Information Session
Detailed discussion of MSC mechanisms, physical therapy protocol, nutrition protocol, procedural steps, realistic goals. Opportunity for questions.
Medical Records Review
Assessment of neurological records, prior interventions, current functional status (ALSFRS‑R). Conducted by medical staff to determine appropriateness.